Role of new vaccinators/pharmacists in life-course vaccination.


Journal

Annals of medicine
ISSN: 1365-2060
Titre abrégé: Ann Med
Pays: England
ID NLM: 8906388

Informations de publication

Date de publication:
Dec 2024
Historique:
medline: 25 10 2024
pubmed: 25 10 2024
entrez: 25 10 2024
Statut: ppublish

Résumé

Vaccines against diseases such as herpes zoster, pneumococcus and influenza are broadly recommended for older adults, but uptake is frequently low. Part of the reason may be that access to adult vaccination can be problematic, particularly for minorities and other under-served populations. Potential barriers include complex procedures, limited resources in healthcare systems and lack of structured infrastructure. The Covid-19 pandemic necessitated rapid expansion of the infrastructure to deliver adult vaccination, and triggered the use of facilities including pharmacies, schools, faith-based organizations, community organizations, shops and hair salons, drive-through centres and mobile vaccination units. Although many such initiatives were temporary, they demonstrated the principle of effective expansion of adult vaccination and education to a range of new providers and settings. Of these, pharmacist involvement in immunization in particular has consistently been shown to be associated with increased immunization rates. This review discusses results from attempts to expand and simplify the adult vaccination process, potentially allowing vaccination to be initiated by the recipient and completed in a single visit. These studies suggest that expanding adult vaccination access to new providers and/or new settings will require development of an integrated plan for preventive healthcare, covering areas such as setting target coverage rates, financial support, and development of immunization information systems accessible to all vaccination providers to maintain accurate immunization records and support interventions such as reminders. The expansion of adult vaccination to settings outside of conventional doctors’ offices and hospitals showed that other settings, with appropriate controls, can safely be used for vaccinationAvailability of adult vaccination through a range of providers and settings could simplify the vaccination process, potentially allowing vaccination to be more easily initiated by the recipientHowever, in many countries this potential is not utilized due to the need for changes to basic infrastructure and legislation covering aspects such as vaccine education, payment for vaccination, and access to immunization information systems.

Sections du résumé

BACKGROUND UNASSIGNED
Vaccines against diseases such as herpes zoster, pneumococcus and influenza are broadly recommended for older adults, but uptake is frequently low.
VACCINATION BOTTLENECK UNASSIGNED
Part of the reason may be that access to adult vaccination can be problematic, particularly for minorities and other under-served populations. Potential barriers include complex procedures, limited resources in healthcare systems and lack of structured infrastructure.
STRESS-TESTING EXPENDED VACCINATION UNASSIGNED
The Covid-19 pandemic necessitated rapid expansion of the infrastructure to deliver adult vaccination, and triggered the use of facilities including pharmacies, schools, faith-based organizations, community organizations, shops and hair salons, drive-through centres and mobile vaccination units.
IMPROVED ADULT VACCINATION SYSTEM UNASSIGNED
Although many such initiatives were temporary, they demonstrated the principle of effective expansion of adult vaccination and education to a range of new providers and settings. Of these, pharmacist involvement in immunization in particular has consistently been shown to be associated with increased immunization rates.
INTEGRATION OF NEW VACCINATORS UNASSIGNED
This review discusses results from attempts to expand and simplify the adult vaccination process, potentially allowing vaccination to be initiated by the recipient and completed in a single visit. These studies suggest that expanding adult vaccination access to new providers and/or new settings will require development of an integrated plan for preventive healthcare, covering areas such as setting target coverage rates, financial support, and development of immunization information systems accessible to all vaccination providers to maintain accurate immunization records and support interventions such as reminders.
The expansion of adult vaccination to settings outside of conventional doctors’ offices and hospitals showed that other settings, with appropriate controls, can safely be used for vaccinationAvailability of adult vaccination through a range of providers and settings could simplify the vaccination process, potentially allowing vaccination to be more easily initiated by the recipientHowever, in many countries this potential is not utilized due to the need for changes to basic infrastructure and legislation covering aspects such as vaccine education, payment for vaccination, and access to immunization information systems.

Autres résumés

Type: plain-language-summary (eng)
The expansion of adult vaccination to settings outside of conventional doctors’ offices and hospitals showed that other settings, with appropriate controls, can safely be used for vaccinationAvailability of adult vaccination through a range of providers and settings could simplify the vaccination process, potentially allowing vaccination to be more easily initiated by the recipientHowever, in many countries this potential is not utilized due to the need for changes to basic infrastructure and legislation covering aspects such as vaccine education, payment for vaccination, and access to immunization information systems.

Identifiants

pubmed: 39453787
doi: 10.1080/07853890.2024.2411603
doi:

Substances chimiques

COVID-19 Vaccines 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

2411603

Auteurs

Lois Privor-Dumm (L)

Johns Hopkins Bloomberg School of Public Health, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH